A study was conducted to determine effects of a mannanoligosaccharide prebiotic, derived from cell wall of the yeast Saccharomyces cerevisiae, on morphological development of the intestines and microbial populations of the ceca and litter. Dietary treatments included: antibiotic-free diet (CTL), diet 1 + virginiamycin (VIRG; 16.5 mg/kg feed) and diet 1 + ActiveMOS (MOS; 1.5 kg/T starter diet and 1 kg/T grower diet). Each treatment was assigned to 3 pen replicates (55 birds/pen). At day 14, 24 and 34, cecal contents were used for Lactobacilli, Bifidobacteria, E. coli and Campylobacter quantification whereas litter was analyzed for Campylobacter and E. coli. At same time points, jejunum samples were used in histological analysis. MOS significantly increased goblet cell number in the jejunum (p<0.05) at day 24 and 34. In contrast to the CTL and VIRG diet, MOS consistently increased cecal populations of Bifidobacteria (p<0.05) at all times. Moreover, at day 34, MOS increased cecal populations of Lactobacilli (p<0.05) and reduced E. coli and Campylobacter concentrations (p<0.05). None of the dietary treatments altered E. coli and Campylobacter concentrations in the litter. In comparison to antibiotics, MOS, therefore, improved intestinal health conditions by increasing goblet cell number into the villi membrane, stimulating growth of beneficial bacteria and reducing colonization by pathogenic bacteria.
INTRODUCTION
Antibiotics as growth promoters have intensely been used for decades in poultry production to improve farm performance and in the control of intestinal pathogens. With increasing interests in discontinuing the use of antibiotics in livestock production, there is much concern about finding natural alternatives to antibiotics that would sustain sound chicken health. Several products with different modes of actions have been proposed, including prebiotics, probiotics, acidifiers and phenolic compounds. Mannanoligosaccharide (MOS), a natural feed additive derived from yeast cell wall, has received profound
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scientific consideration in chickens due to its associated
Bird management and experimental design: Fourintestinal health benefits in the presence or absence of hundred-ninety-five 1-day-old male Cobb 500 broilers antibiotics. For instance, MOS competitively binds to were randomly assigned to 3 dietary treatments (3 pen mannose-specific lectin, namely FimH, of gram-negative replicates; 55 birds per pen). Experimental diets pathogens that express Type-1 fimbriae such a s included: antibiotic-free diet (CTL), VIRG (diet 1 + 16.5 Salmonella and Escherichia coli (Thomas et al., 2004) mg/kg virginiamycin) and MOS (diet 1 + ActiveMOS : 1.5 and result in their excretion of the intestines (Spring et kg/T of starter diet and 1 kg/T of grower diet). Diets were al., 2000; Baurhoo et al., 2007b) . Moreover, MOS formulated to be isonitrogenous, isoenergetic and to substantially increased the number of goblet cells in meet or exceed NRC (1994) requirements for macro and broiler intestines (Baurhoo et al., 2007a) . Goblet cells micronutrients. The basal diet is as previously described are specialized cells that produce and secrete mucins, by Baurhoo et al. (2007a) . A 2-phase feeding program glycoprotein compounds, which bind pathogenic was used including a starter diet starting from day 1-21 microorganisms and reduce their adherence to the and a grower diet from day 22-38. Birds had access to intestinal mucosa (Bloomberg et al., 1993) . These water at all times. represent key mechanisms by which MOS reduce Birds were grown on clean wood shavings in concreteintestinal colonization of pathogens.
floor pens and each pen was equipped with 1 tube But, intestinal health responses vary among different MOS products due to differences in mannoproteins, mannose and glucose compositions which occur depending on the yeast strain used, growing conditions and product manufacturing. The present study aimed at determining effects of a less studied MOS product, derived from cell wall of the yeast Saccharomyces cerevisiae, on morphological development of the intestines and microbial populations of the intestines and litter, in comparison with those of an antibiotic-free diet and one containing the antibiotic, virginiamycin. Microbiological analysis of ceca and litter: At day 24 and 34, birds were euthanized by electrical stunning and bleeding of the carotid artery. Fresh ceca were aseptically removed and used in microbiological analysis respective to birds and treatments (3 birds/ pen). At day 14, considering limited amounts of digesta at the chick's young age, cecal contents from 3 birds were pooled per sample replicate to obtain enough digesta for enumeration of Lactobacilli, Bifidobacteria, Campylobacter, Salmonella and E. coli. Cecal samples were diluted 10-fold by weight in buffered peptone water 4 followed by serial dilution in 0.85% sterile saline solution. All microbiological analyses were performed in duplicates and the average values were used for statistical analysis. Lactobacilli were anaerobically assayed using Lactobacilli MRS Agar and incubated at 37 C for 48 h. 4 o Enumeration of Bifidobacteria was performed using Wilkins-Chalgren agar supplemented with glacial acetic 5 acid (1 ml/L) and mupirocin (100 mg/L) and incubated 4 5 at 37 C for 3 days. E. coli was assayed using Rapid E. o coli 2 agar and E. coli supplement for 24 h at 37 C. Colonies of respective bacteria were counted after the incubation periods. At same bird ages, litter was collected in the middle of each pen and equidistant from each other at each side end of the pen to the floor pen surface and away from the drinker region using examination gloves. Litter samples were thoroughly mixed and kept in sterile microbiological bags at -20 C until analysis. A 10 g o sample was then used for subsequent enumeration of Salmonella, Campylobacter and E. coli as previously described.
Histological analysis: From each euthanized bird, at day 14, 24 and 34, a 1-cm segment of the jejunum was excised, washed in physiological saline solution and fixed in 10% buffered formalin. The tissue samples were then embedded in paraffin and a 2 µm section of each sample was placed on a glass slide and stained with haematoxylin and eosin for histological analysis. Parameters measured included villi height, goblet cell number into villi membrane, muscularis layer thickness 7
Statistical analysis: All data were analyzed by a 1-way ANOVA using the MIXED procedure of SAS (SAS Institute, 2003) with pen nested within treatments. The Scheffe's Multiple Comparison test was used to test differences between treatment means and statistical significance was declared at p<0.05. All microbiological concentrations were subjected to log transformation 10 prior to statistical analysis.
RESULTS
Intestinal morphology: MOS caused major increases in goblet cell number when compared to CTL and VIRG fed birds at both day 24 and 34 (Table 1 ). There were, however, no differences in villi height, crypt depth and muscularis layer thickness among birds fed the CTL, VIRG and MOS diets at all time points.
Microbiology of ceca and litter: MOS consistently increased the cecal concentrations of Bifidobacteria, at day 14, 24 and 34, in comparison to CTL and VIRG fed birds (Fig. 1) . On the other hand, Bifidobacteria seemed to be s ensitive to antibiotic as demonstrated by its reduced concentrations when compared to CTL fed birds at all times. Additionally, MOS significantly increased Lactobacilli concentrations when compared to birds fed the CTL and VIRG diets at day 34; but, Lactobacilli counts were similar between birds fed CTL and VIRG (Fig. 2 ). There were also no treatment differences on Lactobacilli counts among birds in all treatment groups at day 14 and 24. Birds were free of Salmonella similar to previous trials conducted in the same research facility. MOS significantly reduced cecal concentrations of E. coli and Campylobacter at day 34 only when compared to CTL fed birds ( Fig. 3 and 4 , respectively). When the same comparison was made, Campylobacter concentration was lower in VIRG fed birds at day 34. None of the et al., 1987) . Additionally, mucins possess specific mannosyl receptors in the oligosaccharide units that competitively attach to Type-I fimbriae of gram negative pathogens (Sajjan and Forstner, 1990) ; similar mechanism has been proposed for MOS actions in eliminating gram-negative pathogens. The continuous process of mucin secretion coupled with peristalsis movements allows excretion of trapped pathogens from the intestines. Increased mucin secretions due to MOS would, therefore, contribute to greater elimination o f intestinal pathogens. This study also demonstrates that MOS may favorably alter microbial ecology of the chicken intestines. MOS significantly increased intestinal concentrations o f Bifidobacteria and Lactobacilli, but the increase was more pronounced in Bifidobacteria. On the other hand, virginiamycin inhibited growth of these beneficial bacteria due to its bactericidal properties against grampositive bacteria. MOS, therefore, allow establishment of an intestinal population of beneficial bacteria that would limit growth of pathogens by competing for nutrients and bindings sites (Rolfe, 2000) and secreting antibacterial substances (Gibson and Wang, 1994; Jin et al., 1996a,b) . But, the mechanistic approach underlying MOS effects in favoring growth of beneficial bacteria is poorly understood. Our findings suggest that, through competitive exclusion of gram negative pathogenic bacteria possessing Type-I fimbriae, MOS and subsequent mucins secretion offer larger intestinal space for growth of beneficial bacteria. In addition, preferential colonization to glycoprotein receptor sites on the mucus blanket of the intestines by beneficial bacteria than Type-I pathogens such as E. coli has previously been demonstrated (Mack et al., 1999) . Our findings are in agreement with previous reports indicating significant increases in intestinal populations of beneficial bacteria when broilers were fed MOS diets (Fernandez et al., 2002; Baurhoo et al., 2007a,b) . Unfortunately, MOS did not alter intestinal population of beneficial bacteria in other studies (Spring et al., 2000; Fairchild et al., 2001 ) despite significant reduction in pathogenic bacteria concentrations. The mechanistic action of MOS in attaching to Type-I fimbriae of gram negative pathogens and their elimination of the intestine has previously been proposed (Newman, 1994; Thomas et al., 2004) . Our findings suggest that increased mucin secretion and increased growth of beneficial bacteria represent additional key mechanisms underlying MOS actions against intestinal pathogens. The synergistic effects of these MOS effects would enable greater protection against intestinal pathogens. MOS is, thus, an effective dietary strategy that creates conditions of good health in the chicken intestines. A reduction in intestinal E. coli and Campylobacter concentrations was expected t o cause less excretion of these pathogens and consequently less into the litter. But, such scenario was not evidenced in the present study when broilers were fed MOS and virginiamycin diets. The suitable environmental conditions and nutrient-rich contents of broiler litter (Kelleher et al., 2002) might have favored microbial proliferation. Our findings suggest that in addition to its direct effect of attaching to Type-I fimbriae of gram-negative pathogens, MOS action in eliminating intestinal pathogens synergistically occurs via increased mucin production and increased colonization by beneficial bacteria. In the absence of antibiotics, MOS can, therefore, confer greater protection against intestinal pathogens in broiler chickens.
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